Search

everythinglearnresearchcommunity

for

Search:↓

Origanum vulgare leaf extract reduces liver and kidney damage caused by finasteride in mice.

Mesenchymal stem cells show promise for treating various skin conditions and may help regenerate hair.

Ocoxin improves quality of life for advanced ovarian cancer patients on chemotherapy.

Using systemic drugs as creams for skin conditions shows promise, but more research is needed to confirm their effectiveness and safety.

PBX1 reduces aging and cell death in stem cells by boosting SIRT1 and lowering PARP1.

Alopecia areata involves immune response and gene changes affecting hair loss.

Norwegian puffin dogs have a unique type of hair loss that often doesn't get better on its own and responds well to ciclosporin treatment.

UVA1-light therapy successfully treated a child's skin condition, mycosis fungoides.

People with alopecia areata have similar retinal structures but thicker choroidal regions compared to those without the condition.

Early intervention and patient education are crucial for managing alopecia areata.

Alopecia areata is an autoimmune condition causing hair loss, influenced by genetics, stress, and diet, and may be prevented by a high soy oil diet.

The document concludes that ongoing research using animal models is crucial for better understanding and treating Alopecia Areata.

Actinic keratosis is a sun-induced skin condition that can potentially turn into skin cancer and requires treatment to prevent malignancy.

Low vitamin D levels are common in people with Alopecia Areata.

The traditional herbal formulas Yongdamsagan-Tang and Paljung-san, along with the drug finasteride, can reduce inflammation and may work together without affecting each other's effectiveness against benign prostatic hyperplasia.

The document concludes that various skin conditions have specific characteristics and treatments, and highlights the importance of vitamin D in managing these dermatological issues.

Minoxidil and Finasteride are effective for male baldness; more research is needed for hair aging treatments.

Vesiculobullous lesions should be considered part of canine cutaneous epitheliotropic T-cell lymphoma.

CD80CD86 deficiency causes hair loss by disrupting regulatory T cells.

The document concludes that autoimmune skin disorders are treated with corticosteroids and immunosuppressive drugs.

New drugs targeting the JAK-STAT pathway show promise for treating inflammatory skin diseases.

Using methods like lasers and microneedling with drugs can improve hair regrowth for alopecia, but more research is needed on safety and best practices.

Changes to the Foxp3 protein affect how well regulatory T cells can control the immune system, which could help treat immune diseases and cancer.

3-Deoxysappanchalcone helps human hair cells grow and stimulates hair growth in mice by affecting certain cell signaling pathways.

UV radiation may cause DNA changes in skin, certain UVB therapy helps psoriasis, a new gene mutation is linked to mild piebaldism, different immune cells affect psoriasis, a drug promotes hair growth, and some cancer drugs could treat skin barrier issues.

Herpes gestationis is linked to certain antigens, atopic eczema affects T cell populations and may be eased by breastfeeding, higher doses of anti-androgen treatment can improve androgenic alopecia, topical minoxidil increases hair thickness, long-term methotrexate therapy can cause liver fibrosis in psoriasis patients, and Lichen Sclerosus et Atrophicus patients aren't at higher risk for autoimmune disorders.

Hair loss was found in 37.4% of surveyed rural high-school students in Eskisehir, Turkey, affecting their quality of life, especially in general health and mental well-being.

Men generally have more severe COVID-19 cases and higher death rates than women due to biological differences.

Immune cells affect hair growth and could lead to new hair loss treatments.

Male gender and family history predict alopecia areata recurrence.